CAS: 85-87-0 - pyridoxamine
Formula:C8H12N2O2
InChI:InChI=1S/C8H12N2O2/c1-5-8(12)7(2-9)6(4-11)3-10-5/h3,11-12H,2,4,9H2,1H3
InChI key:InChIKey=NHZMQXZHNVQTQA-UHFFFAOYSA-N
SMILES:OC=1C(=NC=C(C1CN)CO)C
- Synonyms:
- 2-Methyl-3-hydroxy-4-aminomethyl-5-hydroxymethylpyridine
- 3-Pyridinemethanol, 4-(aminomethyl)-5-hydroxy-6-methyl-
- 4-(Aminomethyl)-3-hydroxy-5-(hydroxymethyl)-2-methylpyridine
- 4-(Aminomethyl)-5-(Hydroxymethyl)-2-Methylpyridin-3-Ol
- 4-(Aminomethyl)-5-hydroxy-6-methyl-3-pyridinemethanol
- Piridoxamina
- Pyridoxamin
- Pyridoxylamine
Pyridoxylamine
CAS:85-87-0
Pyridoxylamine (pyridoxamine) is an inhibitor of advanced glycation end production (AGEs) and lipoxidation end products …
Formula:
C8H12N2O2
Purity:
99.25%
Color and Shape:
Solid
Molecular weight:
168.19
Ref: TM-T12588
10mg | 45.00 € | |
25mg | 66.00 € | |
50mg | 96.00 € | |
100mg | 123.00 € | |
1ml*10 (DMSO) | 142.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Ref: AN-AG00G603
1g | 528.00 € | |
5mg | 86.00 € | |
10mg | 101.00 € | |
100mg | 120.00 € | |
500mg | 294.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Ref: 4Z-P-8603
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Thursday 16 May 2024
4-(Aminomethyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol
Controlled ProductCAS:85-87-0
Formula:
C8H12N2O2
Color and Shape:
Pale Yellow Solid
Molecular weight:
168.19
Ref: TR-A470870
5mg | 93.00 € | |
10mg | 119.00 € | |
50mg | 143.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
4-(Aminomethyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol
CAS:85-87-0
4-(Aminomethyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol is a metabolite of the nonsteroidal anti-inflammatory drug (NSAID) piroxicam. It has been shown …
Formula:
C8H12N2O2
Purity:
Min. 95%
Molecular weight:
168.2 g/mol
Ref: 3D-AAA08587
1g | 258.00 € | |
50mg | 53.00 € | |
100mg | 86.00 € | |
250mg | 119.00 € | |
500mg | 191.00 € |
Estimated delivery in United States, on Thursday 20 Jun 2024